NCT04494945View on ClinicalTrials.gov

Identifying and Caring for Individuals With Inherited Cancer Syndrome

NAActive, not recruitingINTERVENTIONAL
Enrollment

27,500

Participants

Timeline

Start Date

March 9, 2020

Primary Completion Date

June 10, 2026

Study Completion Date

June 10, 2030

Conditions
BRCA1/2-Associated Hereditary Breast and Ovarian Cancer SyndromeBreast Ductal Carcinoma In SituHematopoietic and Lymphoid System NeoplasmHereditary Neoplastic SyndromeLynch SyndromeMalignant Solid Neoplasm
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of saliva sample

OTHER

Genetic Counseling

Receive genetic counseling if testing results are positive

OTHER

Genetic Testing

Undergo genetic testing

OTHER

Survey Administration

Complete a survey

Trial Locations (2)

97213

Providence Portland Medical Center, Portland

97239

OHSU Knight Cancer Institute, Portland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Oregon Health and Science University

OTHER

lead

OHSU Knight Cancer Institute

OTHER

NCT04494945 - Identifying and Caring for Individuals With Inherited Cancer Syndrome | Biotech Hunter | Biotech Hunter